help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalla Valle, L.
Right arrow Articles by Colombo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalla Valle, L.
Right arrow Articles by Colombo, L.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 10 3702-3709
Copyright © 1998 by The Endocrine Society


Original Studies

Potential for Estrogen Synthesis and Action in Human Normal and Neoplastic Thyroid Tissues1

Luisa Dalla Valle, Annalisa Ramina, Silvia Vianello, Ambrogio Fassina, Paola Belvedere and Lorenzo Colombo

Department of Biology (L.D.V., A.R., S.V., P.B., L.C.) and Institute of Pathological Anatomy (A.F.), University of Padova, Padova, Italy

Address all correspondence and requests for reprints to: Prof. Lorenzo Colombo, Dipartimento di Biologia, Università di Padova, via U. Bassi 58/B, 35121 Padova, Italy. E-mail: colombo{at}civ.bio.unipd.it

To investigate the potential of intracrine or paracrine estrogen synthesis and action in the human thyroid gland and thyroid tumors, the presence of the messenger ribonucleic acids (mRNAs) of both cytochrome P450 aromatase (P450arom) and estrogen receptor (ER) was investigated by RT-PCR with primers designed on the respective coding regions and Southern hybridization analysis with specific probes in neoplastic (n = 42), hyperplastic (n = 7), and adjacent histologically normal thyroid tissues (n = 33) obtained from 43 female and 7 male patients. Most thyroid tissues were positive for both mRNAs, but 2 normal and 3 neoplastic tissues were negative for P450arom mRNA only, 3 normal and 1 hyperplastic tissues were negative for ER mRNA only, and 2 normal tissues were double negative. In some patients, P450arom mRNA was absent in either the neoplastic tissue or the normal one. Single and double negative samples were relatively more frequent in men (n = 4) than in women (n = 7). All negative samples were positive for ß-actin mRNA. RT-PCR amplification and Southern blotting of promoter-specific untranslated 5'-termini revealed that the human thyroid gland and tumors mainly use the ovarian-type promoter, promoter II, for CYP19 expression. Transcripts with either exon I.4 or I.1 were present only in some samples and in very low copy number. When 18 neoplastic samples with their surrounding normal tissues were analyzed immunohistochemically, 57% of those that were positive for P450arom mRNA also had a positive immunoresponse for the corresponding protein. In the case of ER, the percentage was 58%. Immunostaining for P450arom was often particularly intense in neoplastic samples. When 3 adenomata and 1 papillary cancer were incubated with [1,2,6,7-3H]testosterone, 17ß-estradiol could be radiochemically identified with a maximal yield of 10.5 fmol/mg·h.

In conclusion, the human thyroid gland appears to have the potential for both estrogen synthesis and intracrine or paracrine estrogen responsiveness, which seem to be greater in women than men and may become enhanced with the process of tumorigenesis.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Vivacqua, D. Bonofiglio, L. Albanito, A. Madeo, V. Rago, A. Carpino, A. M. Musti, D. Picard, S. Ando, and M. Maggiolini
17beta-Estradiol, Genistein, and 4-Hydroxytamoxifen Induce the Proliferation of Thyroid Cancer Cells through the G Protein-Coupled Receptor GPR30
Mol. Pharmacol., October 1, 2006; 70(4): 1414 - 1423.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
Y Kazeto and J M Trant
Molecular biology of channel catfish brain cytochrome P450 aromatase (CYP19A2): cloning, preovulatory induction of gene expression, hormonal gene regulation and analysis of promoter region
J. Mol. Endocrinol., December 1, 2005; 35(3): 571 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Miki, T. Nakata, T. Suzuki, A. D. Darnel, T. Moriya, C. Kaneko, K. Hidaka, Y. Shiotsu, H. Kusaka, and H. Sasano
Systemic Distribution of Steroid Sulfatase and Estrogen Sulfotransferase in Human Adult and Fetal Tissues
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5760 - 5768.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Fleury, G. Van Melle, V. Woringer, R. C. Gaillard, and L. Portmann
Sex-Dependent Variations and Timing of Thyroid Growth during Puberty
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 750 - 754.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Sumitani, M. Shozu, T. Segawa, K. Murakami, H.-J. Yang, K. Shimada, and M. Inoue
In Situ Estrogen Synthesized by Aromatase P450 in Uterine Leiomyoma Cells Promotes Cell Growth Probably Via an Autocrine/Intracrine Mechanism
Endocrinology, October 1, 2000; 141(10): 3852 - 3861.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. W. Furlanetto, L. Q. Nguyen, and J. L. Jameson
Estradiol Increases Proliferation and Down-Regulates the Sodium/Iodide Symporter Gene in FRTL-5 Cells
Endocrinology, December 1, 1999; 140(12): 5705 - 5711.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society